Sales of $386 million, down five percent from the prior-year quarterPreviously announced Avoca divestiture reduced overall ...

The end of Bristol Cars was both tarnished and unseemly. Given that this was a marque formed over a perfectionist ...

Your Roadmap for mRNA Process Development & Manufacturing with Optimized Purification, Process Analytics & Enhanced Formulation to Improve Cost-Effectiveness & Scalability into the Clinic & Beyond The ...

Maybe just to add to that, OUS as well, we continue to advance or engage new countries that we are going to be launching ...

Corteva, Inc. (NYSE: CTVA) ("Corteva" or the "Company") today reported financial results for the fourth quarter and full-year ended December 31, 2025.

With the cell and gene therapy industry surging, rapid advances in mRNA-based therapies, and the advent of DNA vaccines, the demand for quality DNA as a critical starting and therapeutic material has ...

Net earnings of $5.0 billion, or $21.49 per share, in 2025, including a pension settlement charge of $479 million ...

Aviat Networks, Inc. ("Aviat Networks," "Aviat," or the "Company"), , the leading expert in wireless transport and access solutions, today reported financial results for its fiscal 2026 second quarter ...

Standards make everyday life run smoothly. You rarely notice them: the credit card that works in any corner of the world, the Wi-Fi signal that connects a remote village to the cloud, or the vaccine ...

Total Q2 Revenues of $111.5 million Q2 Operating Income of $7.3 million; Q2 Non-GAAP Operating Income of $9.6 million Q2 Net Income of $5.7 million; Q2 Adjusted EBITDA ...

Seed's industry-leading performance reflects demand for latest technology, productivity savings, and growth in licensing Resilience in Crop Protection evidenced ...

As the MDGs era comes to a conclusion with the end of the year, 2016 ushers in the official launch of the bold and transformative 2030 Agenda for Sustainable Development adopted by world leaders last ...